Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-06
2007-02-06
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140, C514S275000, C544S122000, C544S323000, C544S324000
Reexamination Certificate
active
10271763
ABSTRACT:
The present invention relates to trisubstituted pyrimidines of formula (I)wherein0Rato Reare defined as in claim 1, which are suitable for the treatment of illnesses characterised by excessive or abnormal cell proliferation, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof.
REFERENCES:
patent: 5147876 (1992-09-01), Mizuchi et al.
patent: 6096747 (2000-08-01), Beeley et al.
patent: 6197779 (2001-03-01), Andries et al.
patent: 6200977 (2001-03-01), Cushing et al.
patent: 6235746 (2001-05-01), Davis et al.
patent: 2002/0183335 (2002-12-01), Hewawasam et al.
patent: 2003/0032647 (2003-02-01), Yamada et al.
patent: 2003/0130286 (2003-07-01), Denny et al.
patent: 2003/0171359 (2003-09-01), Dahmann et al.
patent: 2004/0102630 (2004-05-01), Brumby et al.
patent: 2004/0224966 (2004-11-01), Brumby et al.
patent: 2004/0242613 (2004-12-01), Cardozo et al.
patent: 40 29 650 (1992-03-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 945 443 (1999-09-01), None
patent: 1 223 170 (2002-07-01), None
patent: 1 227 741 (2003-01-01), None
patent: 3-127790 (1991-05-01), None
patent: WO 91/18887 (1991-12-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 99/41253 (1999-08-01), None
patent: WO 99/50250 (1999-10-01), None
patent: WO 00/12485 (2000-03-01), None
patent: WO 00/12486 (2000-03-01), None
patent: WO 00/27825 (2000-05-01), None
patent: WO 00/27826 (2000-05-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 00/53595 (2000-09-01), None
patent: WO 01/19825 (2001-03-01), None
patent: WO 01/55148 (2001-08-01), None
patent: WO 01/64653 (2001-09-01), None
patent: WO 01/64654 (2001-09-01), None
patent: WO 01/64655 (2001-09-01), None
patent: WO 01/64656 (2001-09-01), None
patent: WO 02/04429 (2002-01-01), None
patent: WO 02/066036 (2002-08-01), None
patent: WO 02/096888 (2002-12-01), None
Traxler, Protein tyrosine kinase inhibitors in cancer treatment, Exp. Opin. Ther. Patents, 7(6), pp. 571-588, 1997.
Douglas, Jr. Introduction to viral diseases, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1744, 1996.
Lu Valle et al., Cell Cycle Control in Growth Plate Chondrocytes, Frontiers in Bioscience 5, d493-503, May 2000.
Blain et al., Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 nad Cyclin D2-Cdk4, The Journal of Biological Chemistry, vol. 272, No. 41, pp. 25863-25872, 1997.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Bornemann, K. et al; “Trisubstituted Pyrimidines”; U.S. Appl. No. 10/272,160, filed Oct. 16, 2002.
Dahmann, G. et al; Chemical Abstracts, vol. 138:321292, 2003: Corresponds to U.S. 2003/0171359.
Jill Murrel, et al., “A Mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease” Science, vol. 25, pp. 97-99, 1991.
Barbara Cordell “B-Amyloid Formation as a Potential Therapeutic Target for Alzheimer's Disease” Annual Review Pharmacology and Toxicology, 1994, 34:69-89.
Marie-Christine Chartier-Harlin, et al. “Early-onset Alzheimer's Disease caused by Mutations at Codon 717 of the B-amyloid Precursor Protein Gene” Nature, vol. 353, pp. 844-846, 1991.
Martin Citron, et al. “Mutation of the B-amyloid Precursor Protein in Familial Alzheimer's Disease Increases B-protein Production” Nature, vol. 360, pp. 672-674, 1992.
George G. Glenner, et al. “Alzheimer's Disease: Initial Report of the Purification and Characterization of a Novel Cerebrovascular Amyloid Protein” Biochem. Biophys. Res. Comm., vol. 120. No. 3. pp. 885-890. 1984.
K. Johnson-Wood, et al. “Amyloid precursor protein processing and AB42 deposition in a transgenic mouse model of Alzheimer disease” Proc.Natl.Acad.Sci.USA, vol. 94, pp. 1550-1555, 1997.
Dennis J. Selkoe “Amyloid Protein and Alzheimer's Disease” Scientific American, Nov. 1991, pp. 68-78.
Denny et al., Chemical Abstracts, vol. 134:237498, 2001: Corresponds to US 2003/0130286.
EP Patent Abstracts of Japan; Publication No. 01327790; Patent No. JP 3-127790, 1991.
Boschelli, et al; “Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8H-pyrido[2,3-d]pyrimidines: Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors”; J Med Chem, 1998, 41, pp. 4365-4377.
Chemical Abstract: CA 117:48596 for German Patent DE 4029650 A1, 1992.
Barbosa, Jr. et. al., Pyrimidine Derivatives Useful as Inhibitors of PKC-Theta; U.S. Appl. No. 11/175,476 Filed Jul. 6, 2005.
Dahmann Georg
Himmelsbach Frank
Krist Bernd
Lenter Martin
Pautsch Alexander
Boehringer Ingelheim Pharma GmbH & Co. KG
Boehringer Ingelheim Pharmaceuticals Inc.
Datlow Philip I.
Devlin Mary Ellen
Morris Michael P.
LandOfFree
Pyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3817533